Osaic Holdings
VTGN icon

Osaic Holdings’s VistaGen Therapeutics VTGN Stock Holding History

Osaic Holdings’s Portfolio VTGN Stock Details VTGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.36K Sell
4,133
-1,136
-22% -$690 ﹤0.01% 6993
2025
Q4 		$3.48K Buy
5,269
+1,176
+29% +$4.25K ﹤0.01% 6880
2025
Q3 		$14.5K Sell
4,093
-400
-9% -$1.2K ﹤0.01% 6136
2025
Q2 		$8.99K Sell
4,493
-1,001
-18% -$2.27K ﹤0.01% 6222
2025
Q1 		$13.7K Sell
5,494
-5,936
-52% -$16.8K ﹤0.01% 5610
2024
Q4 		$33.7K Buy
11,430
+1,204
+12% +$3.39K ﹤0.01% 4988
2024
Q3 		$30.8K Sell
10,226
-800
-7% -$2.73K ﹤0.01% 5094
2024
Q2 		$38.4K Sell
11,026
-634
-5% -$2.75K ﹤0.01% 4882
2024
Q1 		$61.6K Buy
11,660
+1,194
+11% +$5.74K ﹤0.01% 4591
2023
Q4 		$53.8K Buy
10,466
+5,653
+117% +$21.4K ﹤0.01% 4859
2023
Q3 		$25.2K Buy
4,813
+3,668
+320% +$16.3K ﹤0.01% 5420
2023
Q2 		$2.14K Sell
1,145
-3
-0.3% -$11 ﹤0.01% 6643
2023
Q1 		$4.29K Hold
1,148
– – ﹤0.01% 6402
2022
Q4 		$4K Hold
1,148
– – ﹤0.01% 6433
2022
Q3 		$6K Sell
1,148
-209
-15% -$2.07K ﹤0.01% 6309
2022
Q2 		$36K Buy
1,357
+263
+24% +$9.29K ﹤0.01% 5201
2022
Q1 		$41K Sell
1,094
-329
-23% -$14.3K ﹤0.01% 5240
2021
Q4 		$83K Buy
1,423
+442
+45% +$28.8K ﹤0.01% 4723
2021
Q3 		$81K Buy
981
+515
+111% +$44.8K ﹤0.01% 4716
2021
Q2 		$44K Sell
466
-5,248
-92% -$389K ﹤0.01% 5141
2021
Q1 		$365K Hold
5,714
– – ﹤0.01% 3201
2020
Q4 		$333K Hold
5,714
– – ﹤0.01% 3025
2020
Q3 		$119K Hold
5,714
– – ﹤0.01% 3683
2020
Q2 		$90K Hold
5,714
– – ﹤0.01% 3761
2020
Q1 		$75K Buy
+5,714
New +$105K ﹤0.01% 3693

Other funds holding VTGN

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Osaic Holdings's VTGN Position: Q1 2026 in Review

Osaic Holdings reduced its VistaGen Therapeutics (VTGN) stake by 22% in Q1 2026, selling an estimated $690 and leaving 4,133 shares worth $2.36K. The position accounts for ﹤0.01% of the portfolio, ranked #6993.

Osaic Holdings first reported a position in VTGN in Q1 2020 and has held it in 25 quarters since. The position peaked at $365K in Q1 2021. 56 funds tracked by Wall St. Rank hold VTGN as of Q1 2026.

  • Osaic Holdings held 4,133 shares of VistaGen Therapeutics worth $2.36K as of Q1 2026.
  • Osaic Holdings sold 1,136 VistaGen Therapeutics shares in Q1 2026, an estimated $690.
  • VistaGen Therapeutics made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2026, its #6993 holding.
  • Osaic Holdings first reported a position in VistaGen Therapeutics in Q1 2020 and has held it in 25 quarters since.
  • Osaic Holdings's VistaGen Therapeutics position peaked at $365K in Q1 2021.
  • 56 funds tracked by Wall St. Rank held VistaGen Therapeutics as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.